ES8206481A1 - Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina - Google Patents

Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina

Info

Publication number
ES8206481A1
ES8206481A1 ES505423A ES505423A ES8206481A1 ES 8206481 A1 ES8206481 A1 ES 8206481A1 ES 505423 A ES505423 A ES 505423A ES 505423 A ES505423 A ES 505423A ES 8206481 A1 ES8206481 A1 ES 8206481A1
Authority
ES
Spain
Prior art keywords
maleate
carbethoxyamino
benzylamino
fluoro
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505423A
Other languages
English (en)
Other versions
ES505423A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of ES505423A0 publication Critical patent/ES505423A0/es
Publication of ES8206481A1 publication Critical patent/ES8206481A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE MALEATO DE 2-AMINO-3-CARBETOZIAMINO-6-FLUORO-BENCILAMINO)-PIRIDINA. CONSISTE EN LA REACCION DE 2-AMINO-3-CARBERTOXIAMINO-6-(P-FLUORO-BENCILAMINO)-PIRIDINA CON ACIDO MALEICO EN LA PROPORCION MOLAR RESPECTIVA DE 1 : 1, 1 A 5. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, A UNA TEMPERATURA COMPRENDIDA ENTRE 20 C. Y LA DE EBULLICION DEL DISOLVENTE EMPLEADO. SE PUEDE UTILIZAR COMO MATERIA PRIMA A BASE BRUTA TRATADA CON CARBON ACTIVO. ESTE COMPUESTO TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANALGESICA Y ANTIFLOGISTICA.
ES505423A 1980-09-13 1981-09-11 Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina Expired ES8206481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3034638 1980-09-13

Publications (2)

Publication Number Publication Date
ES505423A0 ES505423A0 (es) 1982-08-16
ES8206481A1 true ES8206481A1 (es) 1982-08-16

Family

ID=6111900

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505423A Expired ES8206481A1 (es) 1980-09-13 1981-09-11 Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina

Country Status (31)

Country Link
US (1) US4481205A (es)
JP (1) JPS5781465A (es)
KR (1) KR860000585B1 (es)
AR (1) AR229101A1 (es)
AT (1) AT375924B (es)
AU (1) AU541020B2 (es)
BE (1) BE890331A (es)
CA (1) CA1147736A (es)
CH (1) CH646952A5 (es)
CS (1) CS226037B2 (es)
DD (1) DD201786A5 (es)
DK (1) DK159878C (es)
EG (1) EG15446A (es)
ES (1) ES8206481A1 (es)
FI (1) FI79531C (es)
FR (1) FR2490225B1 (es)
GB (1) GB2084138B (es)
GR (1) GR75777B (es)
HU (1) HU182720B (es)
IE (1) IE51547B1 (es)
IL (1) IL63801A (es)
IN (1) IN155674B (es)
IT (1) IT1171520B (es)
LU (1) LU83633A1 (es)
NL (1) NL189856C (es)
NO (1) NO160919C (es)
PL (1) PL130030B1 (es)
SE (1) SE454693B (es)
SU (1) SU1091855A3 (es)
YU (1) YU43037B (es)
ZA (1) ZA816336B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
JPH0568848U (ja) * 1991-11-18 1993-09-17 京都機械工具株式会社 チューブ絞り器
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
DE19716984A1 (de) * 1997-04-23 1998-10-29 Asta Medica Ag Verfahren zur Herstellung von reinem Flupirtin-Maleat und dessen Modifikation A
US6187324B1 (en) * 1998-08-11 2001-02-13 Kabushiki Kaisha Ogi Kogei Cosmetic composition comprising at least one of Kumazasa extract and medicinal carbon
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8501778B2 (en) 2008-06-20 2013-08-06 Nhwa Pharma. Corporation Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
CA2738866A1 (en) * 2008-08-06 2010-02-11 Bionevia Pharmaceuticals, Inc. Flupirtine hydrochloride maleic acid cocrystal
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
CN102140077A (zh) * 2010-01-28 2011-08-03 范扶民 氟吡汀a晶型及其制备方法
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102241626B (zh) * 2011-05-03 2013-07-03 北京华睿鼎信科技有限公司 一种马来酸氟吡汀的合成工艺
WO2013080215A1 (en) 2011-11-30 2013-06-06 Arch Pharmalabs Limited An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof
CN103086963A (zh) * 2013-01-29 2013-05-08 吉林修正药业新药开发有限公司 一种马来酸氟吡汀a晶型化合物及中间体的合成方法
CN104086481B (zh) * 2014-07-18 2016-05-11 四川新斯顿制药股份有限公司 一种马来酸氟吡汀的合成方法
CN111100010A (zh) * 2019-12-30 2020-05-05 山东省越兴化工有限公司 一种对氟苄胺的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) * 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
US3969361A (en) * 1972-05-10 1976-07-13 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 2-Benzoyl-3-amino-pyridines

Also Published As

Publication number Publication date
HU182720B (en) 1984-03-28
IT8149272A0 (it) 1981-09-11
DK159878C (da) 1991-05-13
IT1171520B (it) 1987-06-10
FI79531B (fi) 1989-09-29
GB2084138B (en) 1984-07-25
NL189856B (nl) 1993-03-16
IE51547B1 (en) 1987-01-07
ES505423A0 (es) 1982-08-16
NL8104211A (nl) 1982-04-01
NL189856C (nl) 1993-08-16
IL63801A0 (en) 1981-12-31
ATA393481A (de) 1984-02-15
FI812836L (fi) 1982-03-14
FI79531C (fi) 1990-01-10
DK404681A (da) 1982-03-14
GB2084138A (en) 1982-04-07
DK159878B (da) 1990-12-24
BE890331A (fr) 1982-03-11
AU7516381A (en) 1982-03-25
AT375924B (de) 1984-09-25
AU541020B2 (en) 1984-12-13
JPH0259149B2 (es) 1990-12-11
KR830007556A (ko) 1983-10-21
IN155674B (es) 1985-02-23
CA1147736A (en) 1983-06-07
SE454693B (sv) 1988-05-24
FR2490225B1 (fr) 1985-09-06
CH646952A5 (de) 1984-12-28
IL63801A (en) 1984-10-31
SE8105425L (sv) 1982-03-14
FR2490225A1 (fr) 1982-03-19
NO813082L (no) 1982-03-15
CS226037B2 (en) 1984-03-19
AR229101A1 (es) 1983-06-15
US4481205A (en) 1984-11-06
YU215781A (en) 1984-02-29
YU43037B (en) 1989-02-28
PL232999A1 (es) 1982-08-16
GR75777B (es) 1984-08-02
JPS5781465A (en) 1982-05-21
PL130030B1 (en) 1984-07-31
EG15446A (en) 1986-06-30
NO160919C (no) 1989-06-14
ZA816336B (en) 1982-09-29
DD201786A5 (de) 1983-08-10
IE812055L (en) 1982-03-13
KR860000585B1 (ko) 1986-05-17
LU83633A1 (de) 1982-01-21
NO160919B (no) 1989-03-06
SU1091855A3 (ru) 1984-05-07

Similar Documents

Publication Publication Date Title
ES8206481A1 (es) Procedimiento para la preparacion de maleato de 2-amino-3- carbetoxiamino-6-(para-fluor-bencilamino)-piridina
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
ES8800272A1 (es) Un procedimiento para la preparacion de polipeptidos.
JPS5681852A (en) Spectral sensitizer for photoconductive substance and photoconductive composition containing it
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
IE832680L (en) Nitrosourea derivatives.
FR2373590A1 (fr) Solvants de colorants pour la preparation de papiers copiants sans carbone
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
IE32946L (en) Phenethylamine derivatives
GB1498857A (en) Antidepressant composition
ES8105367A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos
ES8609331A1 (es) Un procedimiento para preparar 2-bencil-7,7-dimetil-6,8- dioxa-2-espiro(3,5)nonano
EP0034721A3 (en) Polypeptide and its production and use
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
JPS559665A (en) Liquid crystal composition
ES438537A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1-(2', 4', 6',-trihidroxifenil)-propandiona-(1, 2) sustitui-dos en la posicion 3.
JPS5522622A (en) Preparation of epoxyterpene
GB1457950A (en) Antibacterial compositions
GB1444558A (en) Pyridylthioureas
IE791205L (en) Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use
JPS5247027A (en) Preparation of monoazomethine pigment of barbituric acid
JPS5387358A (en) Gamma-pyrone compound, its preparation and agricultural medicine therefrom

Legal Events

Date Code Title Description
PC1A Transfer granted